There are many active research projects accessing and applying shared ADNI data. Use the search above to find specific research focuses on the active ADNI investigations. This information is requested annually as a requirement for data access.
Principal Investigator | |
Principal Investigator's Name: | Jia Fan |
Institution: | The second hospital of Jilin University |
Department: | Neurology |
Country: | |
Proposed Analysis: | We proposed to analyse the data of ADNI like demographic characteristics, clinical data,some subscales of neuropsychologicalscreens, dneuroimaging results ,biomarkers data and our Chinese data. Try to understand the similarities and differences between Chinese and white patients with AD and MCI. That is important because any ethnic-specifific differences could impact the interpretation of research or clinical trials utilizing diverse participants, particularly if clinical or neuroimaging measures are used to assess treatment outcome. |
Additional Investigators | |
Investigator's Name: | Shanji Nan |
Proposed Analysis: | We proposed to analyse the data of ADNI like demographic characteristics, clinical data and some subscales of neuropsychological screens,and neuroimaging results ,biomarkers data and our Chinese data. Try to understand the similarities and differences between Chinese and white patients with AD and MCI. That is important because any ethnic-specifific differences could impact the interpretation of research or clinical trials utilizing diverse participants, particularly if clinical or neuroimaging measures are used to assess treatment outcome. |
Investigator's Name: | Yuke Ma |
Proposed Analysis: | We proposed to analyse the data of ADNI like demographic characteristics, clinical data and some subscales of neuropsychological screens,and neuroimaging results ,biomarkers data and our Chinese data. Try to understand the similarities and differences between Chinese and white patients with AD and MCI. That is important because any ethnic-specifific differences could impact the interpretation of research or clinical trials utilizing diverse participants, particularly if clinical or neuroimaging measures are used to assess treatment outcome. |